161 related articles for article (PubMed ID: 20113699)
1. ATA practice guidelines for the treatment of differentiated thyroid cancer: were they followed in the United States?
Famakinwa OM; Roman SA; Wang TS; Sosa JA
Am J Surg; 2010 Feb; 199(2):189-98. PubMed ID: 20113699
[TBL] [Abstract][Full Text] [Related]
2. Medullary thyroid cancer: are practice patterns in the United States discordant from American Thyroid Association guidelines?
Panigrahi B; Roman SA; Sosa JA
Ann Surg Oncol; 2010 Jun; 17(6):1490-8. PubMed ID: 20224861
[TBL] [Abstract][Full Text] [Related]
3. Treatment patterns of aging Americans with differentiated thyroid cancer.
Park HS; Roman SA; Sosa JA
Cancer; 2010 Jan; 116(1):20-30. PubMed ID: 19908255
[TBL] [Abstract][Full Text] [Related]
4. Have 2006 ATA practice guidelines affected the treatment of differentiated thyroid cancer in the United States?
Goffredo P; Roman SA; Sosa JA
Thyroid; 2014 Mar; 24(3):463-71. PubMed ID: 23978295
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy.
Vassilopoulou-Sellin R; Schultz PN; Haynie TP
Cancer; 1996 Aug; 78(3):493-501. PubMed ID: 8697396
[TBL] [Abstract][Full Text] [Related]
6. Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer.
Handkiewicz-Junak D; Wloch J; Roskosz J; Krajewska J; Kropinska A; Pomorski L; Kukulska A; Prokurat A; Wygoda Z; Jarzab B
J Nucl Med; 2007 Jun; 48(6):879-88. PubMed ID: 17536106
[TBL] [Abstract][Full Text] [Related]
7. Survival in patients with papillary thyroid cancer is not affected by the use of radioactive isotope.
Podnos YD; Smith DD; Wagman LD; Ellenhorn JD
J Surg Oncol; 2007 Jul; 96(1):3-7. PubMed ID: 17567872
[TBL] [Abstract][Full Text] [Related]
8. Contralateral papillary thyroid cancer at completion thyroidectomy has no impact on recurrence or survival after radioiodine treatment.
Grigsby PW; Reddy RM; Moley JF; Hall BL
Surgery; 2006 Dec; 140(6):1043-7; discussion 1047-9. PubMed ID: 17188155
[TBL] [Abstract][Full Text] [Related]
9. Radioactive iodine ablation post differentiated thyroid cancer surgery: an analysis of use and impact of the American Thyroid Association guidelines.
Sia Y; Dave RV; Nour D; Miller JA; Skandarajah AR; Tasevski R
ANZ J Surg; 2019 Nov; 89(11):E502-E506. PubMed ID: 31674140
[TBL] [Abstract][Full Text] [Related]
10. Management and outcome of recurrent well-differentiated thyroid carcinoma.
Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
[TBL] [Abstract][Full Text] [Related]
11. Survival impact of treatment options for papillary microcarcinoma of the thyroid.
Lin HW; Bhattacharyya N
Laryngoscope; 2009 Oct; 119(10):1983-7. PubMed ID: 19655332
[TBL] [Abstract][Full Text] [Related]
12. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review.
Jarzab B; Handkiewicz-Junak D; Wloch J
Endocr Relat Cancer; 2005 Dec; 12(4):773-803. PubMed ID: 16322322
[TBL] [Abstract][Full Text] [Related]
13. Clinical predictors of quality of life in patients with initial differentiated thyroid cancers.
Almeida JP; Vartanian JG; Kowalski LP
Arch Otolaryngol Head Neck Surg; 2009 Apr; 135(4):342-6. PubMed ID: 19380354
[TBL] [Abstract][Full Text] [Related]
14. [Differentiated thyroid carcinoma in children and adolescents: therapeutic strategy according to clinic presentation].
Causeret S; Lifante JC; Borson-Chazot F; Varcus F; Berger N; Peix JL
Ann Chir; 2004; 129(6-7):359-64. PubMed ID: 15297226
[TBL] [Abstract][Full Text] [Related]
15. Extent of disease and practice patterns for medullary thyroid cancer.
Kebebew E; Greenspan FS; Clark OH; Woeber KA; Grunwell J
J Am Coll Surg; 2005 Jun; 200(6):890-6. PubMed ID: 15922202
[TBL] [Abstract][Full Text] [Related]
16. Utilization of total thyroidectomy for papillary thyroid cancer in the United States.
Bilimoria KY; Bentrem DJ; Linn JG; Freel A; Yeh JJ; Stewart AK; Winchester DP; Ko CY; Talamonti MS; Sturgeon C
Surgery; 2007 Dec; 142(6):906-13; discussion 913.e1-2. PubMed ID: 18063075
[TBL] [Abstract][Full Text] [Related]
17. Hürthle cell carcinoma: a clinicopathological study of thirteen cases.
Ozlem Küçük N; Kulak H; Tokmak E; Tar P; Ibiş E; Aras G
Nucl Med Commun; 2006 Apr; 27(4):377-9. PubMed ID: 16531925
[TBL] [Abstract][Full Text] [Related]
18. Factors influencing radioiodine uptake after thyroid cancer surgery.
Bai JB; Shakerian R; Westcott JD; Lichtenstein M; Miller JA
ANZ J Surg; 2015; 85(7-8):572-7. PubMed ID: 23964714
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the surgical completeness after total thyroidectomy for differentiated thyroid carcinoma.
Salvatori M; Raffaelli M; Castaldi P; Treglia G; Rufini V; Perotti G; Lombardi CP; Rubello D; Ardito G; Bellantone R
Eur J Surg Oncol; 2007 Jun; 33(5):648-54. PubMed ID: 17433606
[TBL] [Abstract][Full Text] [Related]
20. [Prospective therapy study in differentiated thyroid carcinoma].
Gemsenjäger E; Heitz P; Martina B
Schweiz Med Wochenschr; 1995 Nov; 125(46):2226-36. PubMed ID: 8525342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
